Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer

Clinical trial NCT02003924 · COMPLETED

Trial details

NCT number: NCT02003924
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nonmetastatic Castration-Resistant Prostate Cancer Prostate Cancer Cancer of the Prostate

Start date: 2013-10-31
Primary completion: 2017-06-28
Enrollment: 1401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.